methyl 3-(methylsulfonyl)thiophene-2-carboxylate | 62353-79-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: methyl 3-(methylsulfonyl)thiophene-2-carboxylate
• 英文别名: 3-methanesulfonyl-thiophene-2-carboxylic acid methyl ester；Methyl 3-(methanesulfonyl)thiophene-2-carboxylate；methyl 3-methylsulfonylthiophene-2-carboxylate
• CAS: 62353-79-1
• 化学式: C₇H₈O₄S₂
• 分子量: 220.27
• InChiKey: ZRXJXXHWOBQCJS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  97.1
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 3-(methylsulfonyl)thiophene-2-carboxylate 在 N-溴代丁二酰亚胺(NBS) 、 硫酸 、 三氟乙酸 作用下， 以42%的产率得到methyl 5-bromo-3-(methylsulfonyl)thiophene-2-carboxylate
  参考文献：
  名称：

  [EN] THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF
  [FR] INHIBITEURS THIOPHÈNES DE ULK1/2 ET LEUR UTILISATION

  摘要：

  Described herein are compounds that are ULK1/2 inhibitors and their use in the treatment of disorders such as cancers.

  公开号：

  WO2023087027A1
• 作为产物：
  描述：

  3-氯磺酰基-2-噻吩甲酸甲酯 在 碳酸氢钠 、 sodium carbonate 、 caesium carbonate 作用下， 以 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 生成 methyl 3-(methylsulfonyl)thiophene-2-carboxylate
  参考文献：
  名称：

  [EN] THIOPHENE ULK1/2 INHIBITORS AND THEIR USE THEREOF
  [FR] INHIBITEURS THIOPHÈNES DE ULK1/2 ET LEUR UTILISATION

  摘要：

  Described herein are compounds that are ULK1/2 inhibitors and their use in the treatment of disorders such as cancers.

  公开号：

  WO2023087027A1

文献信息

• Pyrrole compounds
  申请人：Kajino Masahiro

  公开号：US20080262042A1

  公开（公告）日：2008-10-23

  The present invention provides a compound having a superior acid secretion inhibitory effect and showing an antiulcer activity, which is represented by the formula (I) wherein R 1 is an optionally substituted cyclic group, R 2 is a substituent, R 3 is an optionally substituted alkyl group, an acyl group, an optionally substituted hydroxy group, an optionally substituted amino group, a halogen atom, a cyano group or a nitro group, R 4 and R 5 are each a hydrogen atom, an optionally substituted alkyl group, an acyl group, an optionally substituted hydroxy group, an optionally substituted amino group, a halogen atom, a cyano group or a nitro group, R 6 and R 6′ are each a hydrogen atom or an alkyl group, and n is an integer of 0-3, or a salt thereof.

  本发明提供了一种具有优异的抑制酸分泌作用和显示抗溃疡活性的化合物，其由式（I）表示，其中R1是一个可选取代的环烷基，R2是一个取代基，R3是一个可选取代的烷基、酰基、可选取代的羟基、可选取代的氨基、卤素原子、氰基或硝基，R4和R5分别是氢原子、可选取代的烷基、酰基、可选取代的羟基、可选取代的氨基、卤素原子、氰基或硝基，R6和R6'分别是氢原子或烷基，n为0-3的整数，或其盐。
• Pyrrolopyridine Derivatives And Their Use As Crth2 Antagonists
  申请人：Bala Kamlesh Jagdis

  公开号：US20080114022A1

  公开（公告）日：2008-05-15

  There are provided according to the invention compounds of formula (I), in free or salt form, wherein R1, R2, R3, R4, R5, R6, Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.

  根据本发明提供了公式（I）的化合物，以自由或盐形式提供，其中R1、R2、R3、R4、R5、R6、Q、W、X、m、n和p如规范中所述，制备它们的过程以及它们作为药物的用途。
• Organic Compounds
  申请人：Sandham David Andrew

  公开号：US20080312230A1

  公开（公告）日：2008-12-18

  There are provided according to the invention compounds of formula (I), in free or salt form, wherein R 1 , R 2 R 3 R 4 , R 5 , R 6 , Q, X, m, n, and p are as described in the specification, on process for preparing them, and their use in the manufacture of a medicament for the treatment of neuropathic pain.

  根据本发明，提供了具有式（I）的化合物，以自由或盐形式存在，其中R1，R2R3R4，R5，R6，Q，X，m，n和p如规范中所述，以及制备它们的过程，并将它们用于制造用于治疗神经病性疼痛的药物。
• Organic compounds
  申请人：Bala Kamlesh Jagdis

  公开号：US20100210610A1

  公开（公告）日：2010-08-19

  There are provided according to the invention compounds of formula (I), in free or salt form, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.

  根据本发明提供了式（I）的化合物，以自由形式或盐形式提供，其中R1、R2、R3、R4、R5、R6、Q、W、X、m、n和p如说明书中所述，以及制备它们的过程和它们作为药物的用途。
• PYRROLOPYRIDINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS
  申请人：Novartis AG

  公开号：US20130267518A1

  公开（公告）日：2013-10-10

  There are provided according to the invention compounds of formula (I) in free or salt form, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Q, W, X, m, n and p are as described in the specification, process for preparing them, and their use as pharmaceuticals.

  根据本发明提供了化合物(I)的自由或盐形式，其中R1、R2、R3、R4、R5、R6、Q、W、X、m、n和p如规范所述，以及制备它们的过程，以及它们作为药物的用途。